Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 2, 1997, Pages 37-41

  Schmidt, Susanne ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ACE gene; Angiotensinogen gene; AT1 receptor gene; Diabetic nephropathy; Genetics; Type II diabetes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSIS; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGED; ALBUMINURIA; ALLELES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0030845077     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the aetiology of type I diabetes mellitus and its complications N Engl J Med 1987; 317: 1390-1398
2. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-11651
3. Pettitt DJ, Saad MF, Bennett PH et al. Familial predisposition to renal disease in two generations of Pima Indians with type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 438-443
4. Bjorck S, Mulec H, Johnson SA et al. Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992; 304:339-343
5. Laffel LM, McGill JB, Gans DJ. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 1995; 99:497-504
6. Hallab M, Bled F, Ebran JM et al. Elevated serum angiotensin converting enzyme activity in type I, insulin-dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 1992; 29: 82-85
7. Rigat B, Hubert C, Alhenc-Gelas, Cambien F, Corvol P, Soubrier F. An insertion/deletion-polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346
8. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290:33-40
9. Jeunemaitre X, Lifton RP, Hunt SC, et al. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992; 1: 72-75
10. Harrap SB, Davidson HR, Connor JM et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993:21: 455-460
11. Schmidt S; van Hooft IMS, Grobbee DE et al. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993; 11: 345-348
12. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potential risk factor for myocardial infarction. Nature 359; 641-644, 1992
13. Marian AJ, Yu Q, Workman R et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1994; 342: 1085-86
14. Raynolds MV, Bristow MR, Bush EW et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-1075
15. Tarnow L, Cambien F, Rossing P et al. Insertion/Deletion polymorphism in the angiotensin-1-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38: 798-803
16. Ruiz J, Blanché H, Cohen N et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-3665
17. Marre M, Bernadet P, Gallois Y et al. Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388
18. Schmidt S, Schöne N, Ritz E and Diabetic Nephropathy Study Group. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995; 47: 1176-1181
19. Schmidt S; Strojek K, Grzeszczak W, Bergis K, Ritz E and Diabetic Nephropathy Study Group. Excess of DD-homozygotes in patients with type II-diabetes on maintenance hemodialysis. Nephrol Dial Transplant (in press)
20. Graham DE. The isolation of high molecular weight DNA from whole organisms or large tissue masses. Anal Biochem 1978; 85: 609-613
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
22. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711
23. Shanmugan V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Applic 1993; 3: 120-121
24. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-695
25. Fogarty DG, Hughes AE, Nevin NC et al. Functional genetic markers of the renin angiotensin system and the risk of diabetic nephropathy. J Am Soc Nephrol 1994; 5: 376 (Abstract)
26. Parving H-H, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Br Med J 1996, 313: 591-594
27. Harden PN, Geddes C, Rowe PA et al. Polymorphism in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-1542
28. Yoshida H, Mitarai T, Kawamura T et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995; 96: 2162-2169
29. Moriyama T, Kitamura H, Ochi S et al. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 1995; 6: 1674-1678
30. Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. Molecular Basis of Human Hypertension: Role of Angiotensinogen. Cell 1992; 71: 169-180
31. Schmidt S, Sharma AM, Zilch O et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995; 10: 1145-1148
32. Tarnow L, Cambien F, Rossing P et al. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996; 45: 367-369